Nuvalent Insider Trades

NUVL

Track insider trading activity from Nuvalent executives and directors. See which insiders are buying and selling NUVL stock.

Trades Last 12 Months

NUVL Price

All Insider Trades for Nuvalent

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Wheeler Cameron Director
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$638k 5,146 shares
$124.00
$123.96
Bogle Grant C. Director
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.81M 14,575 shares
$123.96
$123.96
Noci Darlene Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$2.11M 17,017 shares
$124.00
$123.96
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.51M 12,210 shares
$123.96
$123.96
Pelish Henry E. Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21.5M 173,703 shares
$123.96
$123.96
Porter James Richard President And CEO
Holding Value $4.96M 40,025 shares
Last Trade
Jul 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.96M 40,025 shares
$123.96
$123.96
Protopapas Anna Director
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.1M 81,380 shares
$123.96
$123.96
Squarer Ron Director
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.33M 10,699 shares
$123.96
$123.96
Srivastava Sapna Director
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$14.2M 114,880 shares
$123.96
$123.96
Turner Christopher Durant Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$3.91M 31,530 shares
$124.00
$123.96
Balcom Alexandra Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$48.5M 390,882 shares
$123.96
$123.96
Flynn James E 10% owner, other, Director By Deputization
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$638k 5,146 shares
$124.00
$123.96
Lane Benjamin See Remarks
Holding Value $883k 7,120 shares
Last Trade
Jul 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$883k 7,120 shares
$123.96
$123.96
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$638k 5,146 shares
$124.00
$123.96
Miller Deborah Ann Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Jul 15, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$45.5M 366,712 shares
$123.96
$123.96
Shair Matthew Director
Holding Value $171M 1,382,675 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$820k 7,500 shares
$109.37
$123.96
Pearlberg Joseph Director
Holding Value $638k 5,146 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$313k 4,147 shares
$75.53
$123.96
Holding Value $179M 1,447,267 shares
Last Trade
Dec 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$110M 1,250,000 shares
$88.00
$123.96
Conley Emily Director
Holding Value $311k 2,507 shares
Last Trade
Aug 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$283k 3,334 shares
$85.02
$123.96
Holding Value $470k 3,789 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$303k 3,789 shares
$80.03
$123.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up